Anhui Angkofeng Partners with Two Major Institutions for Strategic Cooperation to Promote Innovation in Traditional Chinese Medicine Photoelectric Technology

May 10, 2025, Anhui Angkefeng Optoelectronics Technology Co., Ltd. (hereinafter referred to as "Angkefeng") officially signed a Comprehensive Cooperation Agreement with Shandong Academy of Traditional Chinese Medicine and Qilu New Energy Innovation Research Institute at the 3rd meeting room on the second floor of the Advanced Technology Research Institute of University of Science and Technology of China. The three parties will engage in in-depth collaboration around "Chinese medicine research and achievement transformation," creating an innovative benchmark for the Chinese medicine industry through the cross-domain integration of "traditional Chinese medicine research + achievement transformation + optoelectronic technology."

Tri-party synergy creates a "Research-Transformation-Technology" full-chain system

This collaboration represents a precise complement of resources among the three parties.

Shandong Academy of Traditional Chinese Medicine, as the national core unit for Artemisinin research and the holder of the industrialized technology for artificial musk, boasts over 60 years of accumulation in traditional Chinese medicine research and development. It has undertaken more than 260 national and provincial-level projects, received over 240 awards at various levels of scientific and technological progress, including the National Science and Technology Progress Award, and is a leading force in the research of Chinese medicinal germplasm resources and new drug development.

Qilu Zhongke New Energy Innovation Research Institute is a key-supported new research and development organization in Jinan City, focusing on the transformation and industrialization of scientific and technological achievements. It excels in technology introduction, cultivation of high-end talent teams, and investment in science and technology projects.

AnGongFeng, as a leading agricultural photonics enterprise incubated by the University of Science and Technology of China's Advanced Technology Research Institute, has been deeply involved in plant photobiological environment control technology for over a decade. The company boasts over 80 authorized patents related to optical agriculture and leads in the fields of intelligent lighting systems and precise control of artificial climate environments.

The three parties are committed to "complementary strengths and common development," aiming to promote the traditional Chinese medicine industry from "experience-based cultivation" to "precision regulation" through cross-domain collaboration.

Establishing the "Luyao Germplasm Resource Laboratory", Focusing on Outcome Transformation

Under the agreement, the core carrier of the trilateral cooperation is the "Luyao Germplasm Resource Innovation and Application Laboratory," with clear division of labor:

Shandong Academy of Traditional Chinese Medicine ResearchAs the laboratory's main entity, responsible for project initiation, scientific research space, and technical resource support.

Qilu Zhongke New Energy InstituteLeveraging our resource integration strengths, we have introduced advanced technologies and top-tier talent teams from home and abroad to assist in攻克 laboratory's key technologies.

Anhui AngkefengOur focus is on "Optical Technology Empowerment," providing professional design and guidance for light environment control technology to laboratories, and collaborating on the application for scientific research projects.

Additionally, the three parties will collaborate on the cultivation of traditional Chinese medicinal herbs and product development, promote the transformation of scientific research achievements into practical applications, and establish a regular consultation mechanism. This will be facilitated through designated contact persons to coordinate the details of the cooperation, ensuring the efficient achievement of goals. The agreement is valid for 5 years (from May 10, 2025, to May 10, 2030) and may be renewed for further deepening of the partnership upon expiration.

Empowering Traditional Chinese Medicine with Light, Unveiling a New Chapter in the Industry

"This signing marks a significant breakthrough for Angkongfeng in the field of agricultural optoelectronics and is a key practice in serving China's 'modernization of traditional Chinese medicine' strategy," said a responsible person from Angkongfeng. "Relying on the incubation background of the Advanced Technology Research Institute of University of Science and Technology of China, we will take the 'Luyao Germplasm Resource Laboratory' as a foundation to explore the application of optical technology in the cultivation and growth environment regulation of traditional Chinese medicine materials, and promote the industrialization of 'light + medicine' technology."

Shandong Academy of Chinese Medical Sciences and the representatives of Qilu New Energy Institute emphasized at the ceremony that the trilateral cooperation will effectively bridge the "research-science-industry" chain, not only promising high-value scientific research outcomes but also providing a replicable model for the transformation of scientific and technological achievements in the field of traditional Chinese medicine, a "Shandong-Anhui" collaborative approach.